Organogenesis Holdings, Inc. (ORGO)
4.03
+0.11
(+2.81%)
USD |
NASDAQ |
Feb 24, 12:46
Organogenesis Holdings Market Cap : 511.46M for Feb. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Integra LifeSciences Holdings Corp. | 909.39M |
| Celularity, Inc. | 37.78M |
| ACADIA Pharmaceuticals, Inc. | 4.197B |
| Alnylam Pharmaceuticals, Inc. | 43.77B |
| Savara, Inc. | 1.173B |
Market Cap Related Metrics
| PS Ratio | 1.118 |
| PEG Ratio | -0.5627 |
| Price to Book Value | 2.005 |
| Price | 4.03 |
| Earnings Yield | -2.43% |
| PEGY Ratio | -0.5627 |
| Operating PE Ratio | 288.11 |